Additionally, the COVID-19 pandemic has underscored the importance of robust supply chain management in the pharmaceutical industry. Disruptions caused by the pandemic prompted many intermediates manufacturers to reassess their supply chain strategies, leading to an increased emphasis on local sourcing and diversification of suppliers. This shift aims to mitigate risks associated with global supply chains and ensure a stable flow of materials.
Drug intermediates play a crucial role in the pharmaceutical industry, serving as essential building blocks in the synthesis of active pharmaceutical ingredients (APIs). These intermediates are not intended for direct therapeutic use; instead, they are chemical compounds that undergo further transformations to produce final drug products. The importance of drug intermediates cannot be understated, as they significantly influence both the efficiency and cost-effectiveness of drug development processes.
4. Intellectual Property The chemical pathways and processes used to create API intermediates can be patentable, providing companies with competitive advantages. Protecting these processes is essential for maintaining market exclusivity.